IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital LLC

Q4 2013 Holdings

Filed 2014-02-13 | 6 holdings | $163.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Quintiles Transnational Corp.Common Stock74876Y101$84.5K1,823,57551.7%
Durata Therapeutics, Inc.Common Stock26658A107$40.0K3,130,82424.4%
Chimerix, Inc.(CMRXEUR)Common Stock16934W106$18.5K1,222,94311.3%
Intercept Pharmaceuticals(ICPTUSD)Common Stock45845P108$9.4K137,5195.7%
MEI Pharma, Inc.Common Stock57232I303$6.2K770,0003.8%
Sorrento Therapeutics, Inc(SRNE)Common Stock83587F202$5.0K620,7003.1%